AllCells competitors

Massi Joe E. Kiani (born September 16, 1964) is an Iranian-born American entrepreneur who founded medical technology company Masimo in 1989.

Dr. Erlander has a track record of over 20 years directing drug discovery efforts and developing precision cancer diagnostics. Dr. Erlander joined Trovagene in 2013 as Chief Scientific Officer (CSO) and as of May 2020, he is now Chief Executive Officer (CEO) at Cardiff Oncology (formerly Trovagene). While at Trovagene, he has been instrumental in successfully transitioning the company from cancer-focused diagnostics to being at the forefront of precision cancer therapeutics. Dr. Erlander’s expertise in oncology precision therapeutics is focused on leveraging the intersection of targeted therapies with molecular diagnostics. Prior to joining Trovagene, Dr. Erlander served as CSO at bioTheranostics, a bioMerieux company, which was previously AviaraDx and acquired by bioMerieux. As CSO, he led R&D, Medical & Scientific Affairs and clinical laboratory operations for the development of proprietary predictive tests in oncology for therapy decisions that are currently in treatment guidelines. Dr. Erlander entered therapeutics as a Group Leader and then Research Fellow in drug discovery at Johnson & Johnson. At J&J, Dr. Erlander led both efforts in drug discovery and the use of genomic technologies to identify new drug targets. Previous to this, he was an Assistant Professor at The Scripps Research Institute where he also received his post-doctoral training. Dr. Erlander is an accomplished researcher in oncology therapeutics, diagnostics and genomic technologies with 44 issued U.S. patents and over 50 pending applications. He has co-authored over 90 scientific publications. Dr. Erlander holds a BS degree in Biochemistry from the University of California, Davis; an MS degree in Biochemistry from Iowa State University; and a Ph.D. in Neuroscience from the University of California, Los Angeles.

Brian worked with Strategyn Equity Partners, a mid-market private equity firm and with L.E.K. Consulting, a business strategy management consulting firm where he focused on advising life sciences clients in corporate strategy, product strategy and planning, and transaction support. Brian has also lived and worked in several countries in Africa with the non-profit TechnoServe, where he wrote a grant for and led the launch of a $13M program funded by the Gates Foundation and Coca-Cola to double the incomes of 54,000 farmers. Brian earned his Masters of Business Administration from UC Berkeley’s Haas School of Business, his Masters in Bioscience from the Keck Graduate Institute of Applied Sciences, and Bachelor of Science degrees with honors in molecular biology and in chemistry from Purdue University.